Postoperative atrial fibrillation after aortic valve replacement in patients with aortic valve regurgitation

The aim – to determine the frequency of postoperative atrial fibrillation (POAF) and risk factors for its development in patients with aortic regurgitation who underwent aortic valve replacement.Materials and methods. The study included 86 patients with aortic regurgitation who underwent aortic valve replacement. Patients were divided into 2 groups: Group I – 32 people who developed POAF, Group II – 54 patients without arrhythmia. Demographic, preoperative general clinical, instrumental, and electrophysiological indicators, as well as intraoperative and early postoperative parameters in these groups of patients were compared. Results. Patients in Group І had significantly more hypertension, chronic kidney disease, smoking, and use of median sternotomy. By means of ROC analysis, such predictors of POAF were determined: left atrial diameter, left atrial volume, left atrial volume index (LAVI), LV end-diastolic diameter (LV EDD), LV end-diastolic volume (LV EDV), end-diastolic volume index (EDVI), thyroid-stimulating hormone (TSH) and glomerular filtration rate (GFR), duration of cardiopulmonary bypass, aortic cross-clamp time duration and median sternotomy.Conclusions. The incidence of POAF in patients with aortic valve regurgitation who underwent aortic valve replacement was 37.2 %. Significant risk factors for POAF in these patients were: hypertension, smoking, left atrial diameter > 45.5 mm, its volume > 92.5 cm3, LAVI > 44.4 mL/m2, LV EDD > 63.5 mm, LV EDV > 214.5 mL, EDVI > 106.2 mL/m2, TSH > 4.75 mU/L and GFR < 99.8 mL/min, duration of cardiopulmonary bypass > 69.5 min, aortic cross-clamp time duration > 50.5 min, duration of operation > 155 min, use of median sternotomy.

Authors

Institutions

Publication Details

Journal
Cardiac Surgery and Interventional Cardiology
Published
2025-03-29
DOI
https://doi.org/10.31928/2664-3790-2025.1.1422
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Postoperative atrial fibrillation after aortic valve replacement in patients with aortic valve regurgitation

Borys M. Todurov, F. Hassanzadeh Ghasabeh
Cardiac Surgery and Interventional Cardiology
Cardiac Valve Diseases and Treatments
article

Postoperative atrial fibrillation after aortic valve replacement in patients with aortic valve regurgitation

Borys M. Todurov, F. Hassanzadeh Ghasabeh
article en

Abstract

The aim – to determine the frequency of postoperative atrial fibrillation (POAF) and risk factors for its development in patients with aortic regurgitation who underwent aortic valve replacement.Materials and methods. The study included 86 patients with aortic regurgitation who underwent aortic valve replacement. Patients were divided into 2 groups: Group I – 32 people who developed POAF, Group II – 54 patients without arrhythmia. Demographic, preoperative general clinical, instrumental, and electrophysiological indicators, as well as intraoperative and early postoperative parameters in these groups of patients were compared. Results. Patients in Group І had significantly more hypertension, chronic kidney disease, smoking, and use of median sternotomy. By means of ROC analysis, such predictors of POAF were determined: left atrial diameter, left atrial volume, left atrial volume index (LAVI), LV end-diastolic diameter (LV EDD), LV end-diastolic volume (LV EDV), end-diastolic volume index (EDVI), thyroid-stimulating hormone (TSH) and glomerular filtration rate (GFR), duration of cardiopulmonary bypass, aortic cross-clamp time duration and median sternotomy.Conclusions. The incidence of POAF in patients with aortic valve regurgitation who underwent aortic valve replacement was 37.2 %. Significant risk factors for POAF in these patients were: hypertension, smoking, left atrial diameter > 45.5 mm, its volume > 92.5 cm3, LAVI > 44.4 mL/m2, LV EDD > 63.5 mm, LV EDV > 214.5 mL, EDVI > 106.2 mL/m2, TSH > 4.75 mU/L and GFR < 99.8 mL/min, duration of cardiopulmonary bypass > 69.5 min, aortic cross-clamp time duration > 50.5 min, duration of operation > 155 min, use of median sternotomy.

Cardiac Surgery and Interventional CardiologyVol. 14(1)
Ministry of Health (UA)
Openalex Percentile: Top 91%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Postoperative atrial fibrillation after aortic valve replacement in patients with aortic valve regurgitation — Borys M. Todurov, F. Hassanzadeh Ghasabeh · Cardiac Surgery and Interventional Cardiology (2025) | TGRS Research Map | TGRS